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S U M I - í A R Y
The disturbance of the normal coronary Derfusion of the heart as a result of
thrombosis, atherosclerosts and coronary yascular spasms is one of the maJon
direct causes of cardiac tschaemtc diseases l ike angtna pectorls and cardtac
in fa rc t ions ,  Ca lqum antagon is ts ,  wh ich  pr rmar i l y  inh ib i t  the  so  cê l ied  s low
calcium channels in the plasma membrane, are a relat iyely new group of drugs
used in the treatment of cardlac and coronary drseases. They not only tmprove
the supDly of blood to the myocardium (due to therr vasodrlat ing effects), but
l imit the energy need of the heart through a negative inotropic effect ênd they
show some anttarrhythmtc activi ty as well .
In this thesis the effects of the prrncipal classes of calcium antagonrsts
(v{i th nrfedigine, verapamii,  di l t iazem and bepridi l  ês representatives) on the
coronary vasculature (vasodilatat ion) and the myocardaum (negatiye inotroprsm)
are studied in the normal and ischaemtc rat heart,  A coronary Derfusron moclel
of the heart was chosen, as described original ly in 1897 by oscar Langendorff ,
in which the changes in coronary f low as well  as in myocarcl ial  contracti l r ty
can be measured stmultaneously, lschaemia was induced by a comDlete cessatton
of the coronary f low,
Large dif ferences in yasoselectivi ty were found among the vartous calctum
antagonrsts, For several compounds i t  was observed that the enantiomers showed
a dif ferent stereoselectiyi ty tovíards the coronary vasculature and the myocar-
dium, Furthermore, the Krnetrcs of the effects of these drugg on the coronary
vasculature (f low rncrease) appeared to be much faster than on the heart muscle
(negat ive  ino t rop ism) ;  moreoyer ,  w i th  the  ( - ) -enant iomers  o f  some yerapamr l
congeners i t  tYas found that the wash-out kinetics of the negative inotroprc
e f fec t  were  subs tan t ra l l y  s lower  than fo r  the i r  op t rca l  an t rpodes ,  These
results indicate that imDortant dif ferences exist between the va$cular and
myocardial isochannels. The posit ive inotroDtc effect, which was observed at
low, vasodtlat ing concentrattons of calcrum antagontsts yít th perfusron under
constant pressure condations wês shown not to be a direct (calcium agonistrc)
ac t iv i t y  o f  the  drugs ,  bu t  a  consequence o f  the  Fran | (  S tar l ing  pr inc ip le ,
induced by the vasodtlatat ion rtself  (chapters 2, 3 and 4).
In ischaemic condit ions (no coronary f low) the deplet ion of hrgh energy
phosphates (ATP, CP) incluces a ventr icular drastol ic contracture, which could
be selectivel),  and concentrat ion dependently dela!,ed and inhrbited at energy
saying (negative inotroprc) concentrat lons of al l  calcium antagonrsts studred.
Furthermore, a new, protectiye mechanism was found at the lower, vasodilat ing
concentrat ions of the drugs, result ing In an ,mproved recovery clurtng the
reperfusion phase, f ' loreover, the protective actryrt ies of the calcium antago-
nists cl isplayed a stereoselectivi ty whrch clurrng ischaemia (delay and decrease
of  the  d ias tohc  cont rac turê)  l vas  s imi la r  to  the  s te reose lec t iv i t y  o f  the
normal  negat rye  Ino t rop tc  ac t iv t ty ,  whereas  dur ing  the  reper fusron  phaSe
(accelerat ion of the recovery from the diastol ic contracture) a cloge Daral lel
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was obsefved w i th  the  s te reose lec t rv i ty  o f  the  vasodr la t tng  e f fec t  o f  the
drugs  (chapters  5  and 6) .  In  add i t ion  we have found tha t  the  ca lqum agonrs t
BAY K 8644,  and especra l l y  the  laevoro ta to ry  enant . iomer ,  aggravated  the
d ias to l tc  cont rac ture  and de layed the  recovery i  these e í fec ts  were  shown rn
par t i cu la r  a t  vasoconst r rc t ing  ( reduced oxygen and subs t ra te  avar labr l t y )  and
pos i t i ve  lno t foDrc  ( rncreased enerqy  expend i tu re)  concent ra t rons  (chapter  7 ) ,
A l though ca lc ium antagonrs ts  un t i l  now were  cons idered to  be  ac t iye  agarns t  the
det r imenta l  consequences  o f  i schaemta  on ly  when grven Drophy lac t ica l l y ,  the
nesu l ts  on  the  pro tec t iye  e f fec ts  dur tng  reper fus ion  o f  the  (s te reo tsomers  o f )
vasose lec t iye  comDounds t rong ly  suggest  d t rec t  therapeut rc  e f fec ts  o f  th ts
c lass  o f  d rugs  as  we l l .
Bes ides  s tudres  w i th  the  In tac t  hear t ,  the  second lead in  th rs  thesrs
concerns  b iochemrca l  s tud ies ,  A t  the  membrane leve l .  ca lc rum t ransDor t  across
the  myocard ia l  p lasma membrane (sarco lemma)  was s tudred,  in  par t rcu la r  ATP-
cleDendent Ca2+-transport and Na+/Ca2+-exchange In sarcolemma vesrcles. At
physiological condittons these processes serve to extrude from the heart the
ca lc ium tha t  has  en tered  dur ing  the  cont rac t ion  cyc le .  A  d i f fe ren t ia i  cen t r r fu -
ga t ton  techn lque was used to  ob tarn  pur i f ted  sarco lemma f rom ra t  hear t
yent r i c les .  Inh ib t t ion  o f  these two Drocesses  by  ca lc rum antagonts ts  was no t
found to  be  s te reose lec t ive ,  However ,  c lear  d i f fe rences  rn  d rug  sensr t rv t ty  and
in the slope of the concentrat ion-inhibit ion curves between the ATP-dependent
Caz+-transport and the Na+/Ca2+-exchanger were found. The resuits indrcate that
the  drugs  ac t  no t  on iy  a t  the  leve i  o f  the  s low ca lc rum channe l  bu t  may a lso
in te r fe re  w i th  o ther  (possrb ly  ca lmodu l in -med ia ted)  p rocesses  (chapter  8 ) .
lschaemic sttuations af e usually accompanted by a drop rn DH, whtch alters
the degree of protonation and possrbly the activrty of drugs, However, for
beDrict i l ,  which at pH 7 is Drotonated f or 11'/ . ,  the inhrbit ion of the ATP-de-
pendent Caa+-extrusion and the Na+/Cae+-exchanger appeared to be independent of
the degree of Drotonation. In contrast, the two calcrum transport processes
themse lves  were  s t rong ly  sensr t rve  to  ex terna l l y  aDphect  pH changes (chaD-
ter 9), suggesttng that in tschaemtc condit ions the extnuston of accumulated
Ca2+ may be imparred. ïhis was conftrmed by the observation that membranes
der ived  f rom ischaemtca l l y  DreDer fused ra t  hear ts  indeed showed a  decreased
AïP-dependent  ca lc rum pumping ac t iv i t y ,  Pre t rea tment  w i th  verapamr l  a t  a
relat iyely low concentrat ion wês found to enhance marl(edly the activrty of this
6u2+-pumD before the onset of ischaemia and during the reperfusron Dhase
( c h a p t e r . l 0 ) .
In view of these results, i t  was considered of interest to investigate tf
the modulat ion of the yascular and myocardial rsochannels in the heart,  both in
normoxic and ischaemic condtt ions, could be confirmed at the receptor level.
Thus, calcium antagonist binding sites were $tudied rn membrane fractrons from
normal and ischaemrc rat heaf ts usrng [3H]-(+)-PN 2Oo-110, a dihyclropyr"rdrne
calcium antagonrst selecttve fof the vascular rsochannel, and [3H]-(-)-devapa-
mil,  a calcium antagonrst from the verapamrl group, which is more selectrve for
the myocardium. l t  was found that at negative Inotroprc (energy saving)
concentrat ions verapamil affords pfotection against ischaemia-induced chanqes
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in the number of btndrng sites (Bmax) of t3Hl-(+)-PN a0o-110, Furthermore, at
l o w e r , v a s o d i l a t i n g c o n c e n t r a t i o n s n t f e d i p l n e e x e r t e d a p r o t e c t i v e a c t i v i t y
selective for the reperfuston phase (chapter 11)'
T h e r e s u I t s f r o n e x - v i v o a n d i n - | l t r o s t u d i e s s h o w a c l e a r p r o t e c -
t i v e r o I e o f c a l c i u m a n t a g o n i s t s i n i g c h a e m i a a n d s u p p o r t t h e v i e w t h a t t h e s e
d r u g s | m p r o v e t n e e n e | g y b a l a n c e , t h e i o n i c h o m e o s t a s i s a n d t h e r e m o v a l o f
de t r imentó l  agents  whrch  are  In t imate ly  connected  to  myocard ia l  i schaemtc
0 r s e a 5  e  s .
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